… The model fit was assessed using appropriate residual and goodness-of-… disease, affected
sites (mucosal only or mucosal and skin), duration of disease to the initiation of the treatment …

… The diagnosis of bullous skin diseases is based on the typical skin … there is no cure for
autoimmune blistering diseases, they can … Rituximab is a chimeric type I anti-CD20 monoclonal …

… et al; French study group on autoimmune bullous skin diseases. First-line rituximab …
For the probabilistic sensitivity analyses, each input parameter was fitted into a distribution (…

… diseases are a group of autoimmune bullous disorders … patients with the mucocutaneous
disease, which is contrary to … a one-size-fits-all approach in the management of pemphigus. …

… the ectoderm and is therefore comparable with the skin. Both structures … Mucocutaneous
conditions are a group of disorders mostly confined to the epithelium, thereby involving the skin …

… When drug-induced, the first step in treatment is to stop the offending agent. Given the
autoimmune etiology, CS and rituximab are first-line treatment. Adjuvant steroid-sparing drugs …

… vulgaris is a mucocutaneous autoimmune blistering disease … A limitation of rituximab is that
it depletes all mature B cells … transplant may improve the fitness of Tregs via increase short-…

… is affected by autoimmune diseases. Overall, autoimmune diseases are still difficult to treat,
… Like other complex diseases, eg, cancer, autoimmune diseases develop over several years. …

… uncommon autoimmune blistering disorder affecting the skin … in recalcitrant mucocutaneous
lesions of PV is purported to … Upon treatment with a second course of rituximab, the patient …

… is a group of autoimmune mucocutaneous blistering disorder … for cardiac fitness were
performed before initiating treatment. … all 31 patients treated with rituximab as first-line treatment or …